Fiona Pearce

1.7k citations

66 papers · 751 indexed · h-index 17

Impact in

Rheumatology top 5%
- Otitis Media and Relapsing Polychondritis
- Systemic Lupus Erythematosus Research
Pulmonary and Respiratory Medicine top 10%
- Vasculitis and related conditions

Papers in

Rheumatology 26
- Systemic Lupus Erythematosus Research 9
- Otitis Media and Relapsing Polychondritis 8
- Urticaria and Related Conditions 4
Nephrology 6
- Renal Diseases and Glomerulopathies 5

Co-authors: Peter Lanyon Matthew J. Grainge Richard Hubbard Richard A. Watts Kwong Ng Abhishek Abhishek Megan Rutter Jeremy Royle
Journals: Lara D. Veeken (26 papers)International Journal of Technology Assessment in Health Care (4 papers)Annals of the Rheumatic Diseases (3 papers)Clinical Rheumatology (3 papers)Journal of Medical Economics (2 papers)
Partner nations: United Kingdom Singapore United States

In The Last Decade

Fiona Pearce

57 papers receiving 742 citations

Peers

Countries citing papers authored by Fiona Pearce

Since Specialization

Citations

This map shows the geographic impact of Fiona Pearce's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fiona Pearce with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fiona Pearce more than expected).

Fields of papers citing papers by Fiona Pearce

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fiona Pearce. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fiona Pearce. The network helps show where Fiona Pearce may publish in the future.

Co-authors

The 25 scholars most cited alongside Fiona Pearce, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Fiona Pearce Line = papers co-authored together Fiona Pearce links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Trends in mortality due to haemophagocytic lymphohistiocytosis across 29 European countries from 2011 to 2021: a retrospective, international, population-based study The Lancet Rheumatology ·A. L. M. Muneer, Rodrigo Cantarero, 柳殿勤, Julián Flores Figueroa, Taghreed S. Farag, Mark Bishton, Matthew Collin, Richard Hubbard, Peter Lanyon, Rachel Tattersall, Jessica Manson, Fiona Pearce	2025	0
2	Patient perspectives on the impact of appearance and weight changes attributed to systemic glucocorticoid treatment of rheumatic diseases Lara D. Veeken ·S. Lax, Emma Dures, Saba Hajizadeh, João Carlos Borromeu Piraciaba, Vivien Lowndes, P. Scott Richards, T J P Jayajith, Michael Shepherd, Jill Dawson, Catherine Hill, Susan M. Goodman, Sarah Mackie, Mwidimi Ndosi, Fiona Pearce, Joanna Robson	2025	1
3	Impact of SARS-CoV-2 spike antibody positivity on infection and hospitalisation rates in immunosuppressed populations during the omicron period: the MELODY study The Lancet ·Lisa Mumford, Rachel Hogg, Julián Flores Figueroa, Peter Lanyon, Mary Bythell, Sean McPhail, Joseph Chilcot, Gillian Powter, Graham Cooke, Helen Ward, Helen Thomas, Stephen P. McAdoo, Liz Lightstone, Sean H. Lim, Gavin J. Pettigrew, Fiona Pearce, Michelle Willicombe	2025	1
4	Plain language summaries supporting patient involvement: lessons and guidance from HTAi Patient and Citizen Involvement Interest Group (PCIG) International Journal of Technology Assessment in Health Care ·Anne-Lise Megard, Kate Morgan, José J. Diaz, Elisabeth Oehrlein, Henning Andersen, MARIA CARMEN ORTEGA SAENZ, 晓平, Fiona Pearce, Koros J. Emily	2025	0
5	A case of Lomentospora prolificans endophthalmitis treated with the novel antifungal agent Olorofim Journal of Ophthalmic Inflammation and Infection ·Michael Dong, Fiona Pearce, G. Vengalyte, Sangbum Joo	2024	3
6	A systematic review and meta-analysis of the incidence rate of Takayasu arteritis Lara D. Veeken ·Megan Rutter, 湊秀幸, Peter Lanyon, Matthew J. Grainge, Fiona Pearce	2021	37
7	COVID-19 infection, admission and death among people with rare autoimmune rheumatic disease in England: results from the RECORDER project Lara D. Veeken ·Megan Rutter, Peter Lanyon, Matthew J. Grainge, Richard Hubbard, Emily Peach, Mary Bythell, P Verdón, Takeda Tomosiro, Sarah Stevens, Fiona Pearce	2021	12
8	Estimating the clinical prevalence of Wilson’s disease in the UK JHEP Reports ·栄子国西, Jiang Guo-qing, Jongdee Piromchai, Philip Kaye, Emilie Wilkes, Jonathan Evans, Guruprasad P. Aithal, Gabriela Jones, Fiona Pearce, Aloysious Aravinthan	2021	7
9	Cost-effectiveness analysis of the nonavalent human papillomavirus vaccine for the prevention of cervical cancer in Singapore Vaccine ·Lee Cheng Phua, Cheuk‐Wai Choi, Joseph T. Wu, Mark Jit, Jeffrey Low, Kwong Ng, Fiona Pearce, Matteo Gargantini, Sara Vejdeland	2021	9
10	A landscape analysis of health technology assessment capacity in the Association of South-East Asian Nations region Health Research Policy and Systems ·Merve Abide, Yot Teerawattananon, Saudamini Vishwanath Dabak, Wanrudee Isaranuwatchai, Fiona Pearce, W. C. L. Hemeon, John Willemse, Mayfong Mayxay, Deepak Somasundar, K. Ye. Korniyenko, Sudigdo Sastroasmoro, Kejie Zhou	2021	25
11	Cost‐effectiveness of ribociclib as initial treatment for premenopausal women with advanced breast cancer in Singapore Cancer Reports ·Deyanira Valencia Gualiche, Soo Chin Lee, Fiona Pearce, Kwong Ng, Sara Vejdeland	2020	6
12	Cost-effectiveness analysis of pembrolizumab monotherapy versus chemotherapy for previously untreated advanced non-small cell lung cancer Journal of Medical Economics ·Sara Vejdeland, Daniela Pereira de Vargas, K. M. Paszowski, Chee‐Keong Toh, Deyanira Valencia Gualiche, Fiona Pearce, Kwong Ng	2020	16
13	Assessing the cost-effectiveness of mepolizumab as add-on therapy to standard of care for severe eosinophilic asthma in Singapore Journal of Asthma ·Daniela Pereira de Vargas, K. M. Paszowski, Sara Vejdeland, Mariko Siyue Koh, Tunn Ren Tay, Fiona Pearce, Kwong Ng	2020	17
14	Primary care consultations after hospitalisation for pneumonia: a large population-based cohort study British Journal of General Practice ·Vadsala Baskaran, Fiona Pearce, Rowan Harwood, Tricia M. McKeever, Wei Shen Lim	2020	2
15	Landscape analysis of health technology assessment (HTA): systems and practices in Asia International Journal of Technology Assessment in Health Care ·Yot Teerawattananon, Waranya Rattanavipapong, Lydia Lin, Saudamini Vishwanath Dabak, 超杨, Wanrudee Isaranuwatchai, Shahid A. Shabbir, Zainab Naseef Jassim, Fiona Pearce, Muwenqi Yu, Ryota Nakamura, Raoh‐Fang Pwu, Asrul Akmal Shafie, S. Jayanti, Shankar Prinja, Wendy Babidge	2019	22
16	Cost-Effectiveness Analysis of Sunitinib versus Interferon-Alfa for First-Line Treatment of Advanced and/or Metastatic Renal Cell Carcinoma in Singapore International Journal of Technology Assessment in Health Care ·Bernard Lafargue, Sara Vejdeland, Fiona Pearce, Min Tan, Thomas Liano, Kwong Ng	2019	11
17	The incidence, prevalence, and survival of systemic sclerosis in the UK Clinical Practice Research Datalink Clinical Rheumatology ·Jeremy Royle, Peter Lanyon, Matthew J. Grainge, Abhishek Abhishek, Fiona Pearce	2018	58
18	Comparative efficacy of inhaled medications (ICS/LABA, LAMA, LAMA/LABA and SAMA) for COPD: a systematic review and network meta-analysis International Journal of COPD ·Sara Vejdeland, Daniela Pereira de Vargas, Thomas Liano, Fiona Pearce, Yizhen Pu, Liang Lin, Kelly Iles, Kwong Ng	2018	35
19	Health Technology Assessment and Its Use in Drug Policies: Singapore Value in Health Regional Issues ·Fiona Pearce, Liang Lin, H.Perez Perez Rojaz, Kwong Ng, Lina Triya Mahendra	2018	22
20	Can granulomatosis with polyangiitis be diagnosed earlier in primary care? A case–control study QJM ·Fiona Pearce, Richard Hubbard, Matthew J. Grainge, Richard A. Watts, Abhishek Abhishek, Peter Lanyon	2017	11

About Fiona Pearce

Fiona Pearce is a scholar working on Rheumatology, Nephrology, Pulmonary and Respiratory Medicine, Dermatology and Pathology and Forensic Medicine, having authored 66 papers that have together received 751 indexed citations. Recurring topics across this work include Vasculitis and related conditions (16 papers), Systemic Sclerosis and Related Diseases (10 papers), Systemic Lupus Erythematosus Research (9 papers), Otitis Media and Relapsing Polychondritis (8 papers), Immunodeficiency and Autoimmune Disorders (6 papers), Renal Diseases and Glomerulopathies (5 papers), SARS-CoV-2 and COVID-19 Research (4 papers) and Urticaria and Related Conditions (4 papers). The work is most often cited by research in Rheumatology (210 citations), Pulmonary and Respiratory Medicine (347 citations), Nephrology (70 citations), Genetics (79 citations) and Infectious Diseases (95 citations). Fiona Pearce has collaborated with scholars based in United Kingdom, Singapore and United States. Frequent co-authors include Peter Lanyon, Matthew J. Grainge, Richard Hubbard, Richard A. Watts, Kwong Ng, Abhishek Abhishek, Megan Rutter, Jeremy Royle, Anthea Craven and Peter A. Merkel. Their work appears in journals such as Lara D. Veeken, International Journal of Technology Assessment in Health Care, Annals of the Rheumatic Diseases, Clinical Rheumatology and Journal of Medical Economics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact